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MEDICAL EXPERIMENTATION 
CONCERNING CHEMICAL AND 
BIOLOGICAL WEAPONS FOR MASS 
DESTRUCTION  
Erwin Deutsch* 
This article is the text of a speech originally presented at the Second World Conference on Medical 
Ethics at Gijon, Spain, on 2 October 2002 under the title "Medical Experimentation Concerning 
Chemical and Biological Weapons for Mass Destruction: Clinical Design for New Smallpox 
Vaccines: Ethical and Legal Aspects".  Experimentation on vaccines such as smallpox is subject to 
the usual ethical rules such as the need for informed consent.  However, the participants will not 
often be at risk of catching the disease but expose themselves by taking part in the experimentation.  
Professor Deutsch explores the implications of this, including the position of vulnerable groups 
such as children, those with mental handicaps, and those acting under orders such as the military, 
the police and fire officers. 
I INTRODUCTION 
One of the very first cases reporting medical experimentation concerns vaccine, to be more 
specific, vaccine against smallpox.  Voltaire reports in his Lettres Anglaises about medical 
experimentation on prisoners in London.1  The British envoy to Turkey had reported a tribal custom 
from the Caucasus Mountains where small children were brought into bleeding contact with a 
person suffering from smallpox.  The result was that the children never developed smallpox.  The 
custom was supposedly picked up from the Arabs, though this has never been confirmed.  In 
London, inmates of the Newgate Prison who had been condemned to death were given the chance to 
participate in a trial with what is now known as smallpox virus.  All participants survived and were 
released.  As a result of that trial the inoculation against smallpox became widespread in England.  
Voltaire contrasts this beneficial development with the rigid French attitude where the court in Paris 
had recently disallowed similar experimentation on humans as assault and battery. 
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The biggest medical trial of all times concerned a vaccination as well.  This was the Salk-Polio-
vaccine that was tried out on a few hundred thousand children in the United States in the mid-fifties.  
There, half of the children were given the vaccine and the other half acted as controls.  Many parents 
cheated the system by enrolling their children in different locations for the trial, hoping to be at least 
once in the verum-group.  The experimentation established without doubt the efficacy of the Salk-
vaccine against polio. 
Now the great curse of yesterday returns under the guise of a possible terrorist attack.  We are 
reminded of the attack on the Genuese garrisons on the Crimea in the Middle Ages, to be specific in 
the fourteenth century, where the bodies of pestilence victims were thrown over the barricades into 
the fortified cities.  All this resulted in the flight of the defenders taking with them the pestilence to 
Europe with terrible results. 
II GENERAL RULES OF EXPERIMENTATION 
For new smallpox vaccines the normal rules of medical experimentation apply, but at the outset 
there has to be a stated special feature of the trial: the experimental subjects are often not at 
immediate risk of catching the smallpox.  On the contrary, they are used to establish whether the 
vaccine is safe and effective.  As far as effectiveness is concerned, the trial has some analogy to 
hyper-immunisation of volunteers to produce anti-bodies against an illness they have not contracted 
but that they have been infected with.  From there we know that adequate information and consent 
in writing has to be given. Moreover the participants have to get compensation for untoward damage 
suffered while an experimental subject. 
According to the Declaration of Helsinki2 and generally accepted legal rules which appear in 
pharmaceutical statutes as well as in court cases, it is necessary that the predictable risks and 
burdens are adequate in comparison with the foreseeable benefits to the subjects or to others.  In 
other words, the experimentation has to be medically acceptable as far as the human subjects are 
concerned.  The medical acceptability has to be established according to the prevailing opinion in 
scientific circles, but medical acceptability means as well that the volunteers believe the risks and 
burdens to be tolerable.  This will be established mostly by the information given in connection with 
informed consent.  But the general question of medical acceptability is not one that could be decided 
solely by the scientific community but has to take into account the understanding and expectation of 
the experimental subjects as a group. 
Another equally important requirement is informed consent.  The volunteers should be informed 
about the aims, methods, benefits and risks of the study as well as the discomfort it might entail.  
Experimentation on unknowing subjects has always been illegal and has given rise to criminal 
procedures.  The consent following the information has to be freely given.  There should be no 
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duress, intimidation or deceit.  Taking part in the drug trial is reserved for volunteers: volunteers are 
only persons that can express their free will, chosen upon full information. Consent given under 
intimidation or deceit is not valid and gives rise to criminal and civil legal action.  There is still 
some debate whether soldiers under command of their officers have to give their informed consent 
or are required, at least after some information, to participate.  That problem will be dealt with later 
on. 
There is some uncertainty whether the informed consent should be given in writing, be it that the 
information is contained in a standard form or the consent is written out by the participant.  Unless 
otherwise required by the law, informed consent has no formal prerequisites.  To use written forms 
ensures identical information and establishes proof of the actual giving of the consent.  Anyway, the 
consent has to be given in absolute freedom.  This implies that the experimental subject can 
withdraw the informed consent at any time without giving reasons. 
There should be no experimentation on members of so-called "vulnerable groups".  Such groups 
are children and members of some special organisations with an honour code, for example, police or 
firemen.  Under exceptional circumstances there can be reason to allow medical experimentation on 
vulnerable groups.  The general ban on medical trials is based on their very vulnerability, for 
example, that the participants are not free to give their consent.  Children are usually too small or 
too dependent on their parents.  Members of a group with an honour code might be bound by that 
code to take part together with their colleagues.  But where an illness concerns mostly members of 
the group, for example, typical children’s ailments, medical experimentation on children is 
acceptable.  One of the reasons is that the trial cannot be performed on consenting adults.  But there 
have to be safeguards.  Whether it is really necessary to perform the trial on children has to be 
debated and approved by a committee, usually an ethics committee, with members who are familiar 
with the treatment of children.  There is still the unsolved problem, whether a clinical trial on 
children can make use of a control group.  Here it is necessary to differentiate.  The children in the 
control group should not be subjected to more than minimal participation.  There should be no long-
term or repetitive measures performed on them.  Harm and inconvenience should be minimal. 
There is still some disagreement whether the experimental subjects have to be told who initiated 
the trials and paid for them.  There has been some discussion whether a trial at the Max-Planck-
Institute for Psychiatry in Munich on easily alarmed patients should have included the information 
that it was paid for by the civil defence authorities.  From the point of view that, in medical 
experimentation, information has to be complete, the sponsor should be included. 
At least there can be some financial or other compensation for taking part in the 
experimentation.  Anyway, an innocent victim from the experiment should be compensated without 
having to establish negligence or fault.  The legal basis for financial compensation of loss is 
obvious:  the experimental subjects sacrifice their health for the common welfare. 
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III MEDICAL SAFETY 
The tests concerning the safety of the vaccine are sometimes referred to as "phase I" of a clinical 
trial.  It is the first step into the unknown territory of the new drug.  One of the starting points of 
medical experimentation is that the new drug poses little risk for the volunteer.  This is especially 
true if healthy volunteers are used for testing vaccines.  It is particularly the case if the vaccine 
should work against an illness where there is no cure.  Some recent cases concern the question of 
safety. 
A The Kennedy-Krieger Lead-abatement Study3   
The case concerns the effectiveness of three different methods of reducing environmental lead in 
older homes.  Environmental lead levels were measured using different methods, one standard and 
the other experimental.  Moreover, blood lead levels of young children living in the homes were 
monitored.  The blood lead levels declined in nearly all the children involved in the study.  Two sets 
of parents brought suit claiming that they were not informed that lead remained a potential hazard in 
the home and that high dust levels were found in the home, even when their child’s blood-lead-
levels rose.  It is suspected that it was a house that acted as a "control".  The Baltimore City County 
Court dismissed the law suits summarily.  The Maryland Court of Appeals reversed the lower court; 
it ordered that the law suits should proceed to trial, and stated that a parent cannot consent to a 
child’s participation in non-therapeutic research in which there is any risk of injury or damage to the 
child’s health. 
B Stateville Prison in Illinois 
During the Second World War, there were clinical trials with malaria in Illinois.  The inmates 
were asked to participate, were not promised an early release but were closely monitored.  There 
were no cases of death.  It appears that the volunteers were finally released early. 
IV EFFICACY 
The test whether a drug is efficient is sometimes called "phase III" study.  Usually it is a 
clinically controlled study with at least one group getting the verum and another one serving as a 
control.  The real problem of vaccine experimentation exists in this field of efficacy.  A good many 
cases have touched on this. 
A Bailey v Mandel4  
 In a prison in Maryland, experimentations were going on to prevent or treat typhus, malaria, 
cholera and influenza.  The participants at the experimentation ward were treated much better than 
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the rest of the inmates: they had quiet rooms, air conditioning, TV, and got at least two dollars a 
day.  The case was settled out of court. 
B Somatic Gene Therapy 
The trial concerned the treatment of a rare disease: OTO-deficiency which appears in a serious 
form in small children and in a more benign version at a later age.  Following the advice of an 
ethical expert, the experimental somatic gene therapy was tried out on an eighteen-year old and not 
on small children.  The reason was that the grown-ups could give their informed consent personally.  
The subject died.  The case against the hospital and the ethical advisor as well is based on the 
assumption that a greater risk of a minor illness should not have been run just in order to get the 
personal consent.  The case has not been decided yet. 
C Polio-Salk-Vaccine Trial in 1955 
The first vaccine against polio was tried out on many children.  There are reports claiming that a 
few hundred thousand children took part.  As discussed above, they were divided into two groups.  
One group got the vaccine, the other the placebo.  It is also reported that many parents cheated or at 
least tried to cheat the system by enrolling their children in more than one trial which took place all 
over the country. 
The test whether a vaccine is effective poses tricky ethical and legal questions.  The tests are not 
outlawed by themselves because the experimental subjects lack an illness to be treated or are in no 
immediate danger.  Trials to keep infections, especially epidemics, at bay are allowed.  But on the 
other hand the health and well-being of the experimental subject comes into focus.  If there is more 
than a minimal chance that the experimental subject, especially the members of a control group, can 
catch the agent, then the experimentation should not be allowed.  Even the informed consent of the 
patient does not allow that person to be put in such a mortal danger.  In this instance, the credo of 
the controlled clinical trial, using test groups and placebo groups, should be questioned.  Maybe the 
population in general might work as a control. 
Research subjects obeying orders pose a special problem.  Usually these are military personnel, 
but members of some other professions as well, for example, hospital personnel.  Consent is 
superfluous if you are under duty.  The question is whether the person at risk should be informed.  
In the Thorathast case during the Second World War at Heidelberg University Hospital and in the 
Desert Storm exception to the use of investigational new drugs, it was held that no information had 
to be given to the soldiers.  This should be questioned, not so much on the basis of consent, but to 
keep the people informed about their risk and the possibility of getting compensation. 
V INFORMED CONSENT 
Though normally information precedes consent and most court cases for lack of informed 
consent are based on no or insufficient information, consent is the main legal basis for 
experimentation.  Consent should be given by the experimental subject, as already stated, and has to 
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be completely free without coercion or deceit.  The consent relates back to the information and does 
not go further than what the experimentational subject has heard or read.  The consent has two legal 
sides.  The first one is allowing the invasion of the person.  That way assault and battery in its 
different forms are excluded because of justification by consent.  The other side of the coin is that 
the consenting subject normally bears the risk of damage to health.  It is a different story if there has 
been negligence or if compensation is given, but normally the experimental subject feels the 
consequences. 
Information that leads to consent has to be given completely and exhaustively.  The subject has 
to know what the experimentation entails to the person.  Moreover, the subject has to be told about 
the duration, the discomforts, the risks and probable benefits.  On the basis of that information the 
experimental subject gives the consent: 
A United States v Rose5 
The accused had provided a KZ with viruses and vaccines for experimental purposes.  Two 
groups were constituted, one had been vaccinated, the other one not.  There were probably 729 
probands and at least 154 deaths. 
B United States v Stanley6   
A sergeant of the American Army volunteered for a programme concerning protective clothes 
against chemical warfare.  Without his knowledge he was administered LSD which led to 
hallucinations and loss of memory. 
C Halushka v University of Saskatchewan7 
For fifty dollars a student had participated in an experimentation concerning general 
anaesthaesia.  He had been told that a new medication would be tried out on him and that a catheter 
would be used.   He had stated in writing that he had been fully informed and had absolved the 
University and the doctors from all responsibility.  During the experimentation the catheter reached 
the heart and it stopped beating.  The student was finally saved and sued the University and 
succeeded in the Court of Appeal.   One reason given was that he had not been fully informed about 
the procedure of the catheter and the danger of the experimentation.  The disclaimer was void. 
  
5  Trial of War-Criminals before the Nuremberg Military Tribunals, Vol 2, (USGPO, Washington DC, 1949-
1953) 264. 
6  (1987) 107 S Ct 3054. 
7  (1965) 52 WWR 608 (Saskatchewan Court of Appeal). 
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VI VULNERABLE GROUPS 
Special care has to be given to the members of so-called vulnerable groups.  These groups are 
vulnerable because their understanding of the procedure and the danger or the formation of a free 
will can be questioned.  These groups consist of children, the mentally handicapped and cohesive 
groups like the military, the police and firemen where a single member might not dare to differ from 
the others.  Usually clinical trials with members of one of these groups are only permissible if the 
group itself is in danger.  Contagious diseases that affect children can sometimes be treated only in 
children and a vaccine against the illness has to be tried out on children.  Whether patients who are 
in hospital because of some treatment unconnected with the trial can be used is still hotly debated.  
Mostly it is not regarded as impermissible, but there is special care required in getting informed 
consent. 
A Weiss v Solomon8   
At the Jewish General Hospital in Québec a patient had had surgery on his eyes.  The doctor 
asked him to take part in an experimentation where the efficacy of opthalmological drops should be 
tested.  The hospital's research committee had approved of the patient's participation, but he died of 
a heart attack.  The case of the widow and the patient's children against the doctor and the hospital 
was successful.  The hospital was liable among other reasons because the ethics committee had not 
insisted on fully informed consent about the risks and had allowed the experimentation to take place 
in a room that was not equipped to deal with heart attacks.  Moreover, the patient who had had a 
history of heart trouble should have been excluded. 
B Neilson v The Regents of the University of California9   
The suit was brought by an attorney who had been a member of the Institutional Review Board 
of the University.  He asked for a temporary injunction to prohibit non-therapeutic experiments on 
children.  The trial concerned asthma.  Two groups of children were to be compared, one group had 
parents with asthma, the other had not.  The children would get veni-puncture four times a year and 
later on injections under the skin.  The parents were promised $300 per participant.  The court did 
not grant the injunction because of very narrow grounds.  It looked at the California statute against 
cruelty against children and found that it was not applicable. 
VII CONTROLS, PLACEBOS AND RANDOMISATION 
Medical research is most persuasive if performed by comparison.  This is true for inoculations 
as well.  Using different groups in vaccine trials, one acting as control group, has been rarely 
attempted and has never been fully accepted.  Trials with vaccina-antigene and MVA vaccine in 
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1959 and 1971 against smallpox did not use a control group.  The trial in the Netherlands in 1962 
with combined active-passive vaccination suffered because the homogenity of the group was not 
established.  There had been experimental subjects who had been inoculated earlier. 
The use of placebos in vaccination trials poses serious problems.  As long as different vaccines 
are tested against each other there is the usual uncertainty that justifies medical research.  But 
knowingly to let a group of people face the real danger of contracting the disease without any 
protection has been held unethical, illegal, even criminal.  Informed consent by volunteers does not 
allow the immediate infection of the research subject as was done in the most recent vaccine trial 
against malaria on seventy volunteers in Oxford.  Here the participants were given five bites from 
heavily infectious mosquitoes.  The vaccine is now being tested in the Gambia on 360 adults, half 
will be given the new vaccine and the other half a rabies shot which has the virtue of providing 
useful protection against the disease endemic in the area, rather than being a mere placebo.10  
Naturally, as regards malaria, it is a placebo. 
The uses of placebo have been limited in the most recent version of the Declaration of Helsinki 
by the World Medical Association.11  The use of placebo is allowed where no proven prophylactic, 
diagnostic or therapeutic methods exist.  This rule led to a battle royal between the American 
medical establishment and the World Medical Association.  There is now a "Note of Clarification" 
by the governing body of the World Medical Association that a placebo controlled trial may be 
ethically acceptable when there is compelling, scientifically sound methodological reason to 
compare an intervention to a placebo or if the intervention being studied is of a minor condition and 
the trial will expose those who received a placebo to no additional risk of serious or irreversible 
harm.  The smallpox vaccine trials touch on that issue. 
Randomisation12 is used to avoid freak results and leads to more representative groups.  In 
vaccine trials the number of participants has to be very high.  Because of the large group of 
population involved there is very little room for randomisation. 
  
10  "Malaria vaccine is being tested in the Gambia" (24 August 2002) The Economist 60. 
11  World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving 
Human Subjects (Edinburgh, 2000) C 29. 
12  "Randomisation" means the partition of research subjects into different groups according to a complicated 
formula.  This is already complicated in a trial of a few hundred volunteers.  It is nearly impossible to 
administer to a group of hundred thousands or millions of persons.  Moreover since the control group might 
get a placebo, there is a danger of large-scale cheating the system as was done with the Salk-polio vaccine 
trial in the 1950s in the United States, where parents enrolled their children at more than one place to be at 
least once in the test group. 
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VIII LIABILITY AND COMPENSATION 
If in performing the experimentation or in any other way connected with it there has been 
malpractice, there should be liability because of negligence.13  Negligence implies that a duty of 
care has not been exercised.  The duty is in the first instance an obligation of the doctor who 
performs the trial, but there are secondary duties to be performed by an institutional review board or 
the Government.  If there has been no negligence, there could be some other form of a case for 
compensation.  Compensation does not give full damages, but somehow compensates the innocent 
victim.  For example if the volunteer has given up a right or provided dangerous services.  
Compensation is always due if the experimental subject had not been asked to give informed 
consent, especially if these are soldiers on military orders.  But in some countries there are more 
general rules concerning objective liability or compensation for the risk that materialises in clinical 
experimentation.  Two cases might illustrate that. 
A German Supreme Court14   
A soldier who had suffered an aneurysm on his left leg had been transferred for treatment to the 
Heidelberg University Hospital.  There he underwent an arteriography where radioactive thorathast 
was used.  The main purpose of using thorathast was experimental, because the doubts about the 
safety of thorathast might be dispelled by using it as often as possible.  The soldier suffered cirrhosis 
of the liver as a consequence.  The German Supreme Court stated that the case concerned mostly 
experimentation, but the soldier nevertheless was under orders to participate.  Since there was no 
informed consent, the risk of the experimentation was borne by the government which ordered the 
soldier to obey.  Compensation was granted. 
B Berkovitz v US Supreme Court15   
A two month old infant was given oral polio-vaccine manufactured by the Lederle laboratory.  
Within 2 months he contracted a severe case of polio.  There could be liability of the Federal 
Government if there was failure to exercise or perform a discretionary function or duty on the part 
of the Federal Agency or an employee of the Government.  It was claimed that the NIH division of 
biological standards should not have licensed Lederle to produce.  The Court of Appeal had 
dismissed the case.  The Supreme Court reversed.  It was possible that the conduct challenged did 
not involve a permissible exercise of policy discretion.  If this was the case, then the act of the 
Federal Government was improper. 
  
13  This is subject to legislation to the contrary, as with the accident compensation scheme in New Zealand.  
See the Injury Prevention, Rehabilitation, and Compensation Act 2001. 
14  (1956) BGHZ 20, 61. 
15  (1988) 486 US 531. 
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IX SPECIAL SITUATIONS AND WAR 
The rule of law and the normal ethics considerations apply to normal conditions.  In case there 
are abnormal conditions, there is some relaxation of the rules, but by no means a total disregard.  A 
good case in point is the following court case: 
A Doe v Sullivan16  
During Operation Desert Storm, the main part of the war between the United States and Iraq, 
there was the danger that the other side might use chemical or biological weapons.  Therefore the 
Pentagon asked the Federal Drug Agency (FDA) to use non-approved drugs and vaccines even 
without knowledge of the soldiers in the theatre of war.  Military necessity was given as the reason.  
The FDA granted the exception because there was a war going on and the immediate danger for the 
troups was recognisable.  The case came to court, but in two instances the handling of the case by 
the FDA was upheld for different reasons. 
The war against terror creates another special situation.  There is the actual danger of using 
viruses for terrorist purposes.  Therefore persons who will come into contact with contagious 
diseases might be obliged to be inoculated.  This concerns especially workers in hospitals and other 
health institutions who might get into contact with infected persons early on.  Wherever there is the 
opportunity of developing a new vaccine against smallpox with no known side-effects, 
experimentation should be permissible.  Because of the large number of persons concerned, there 
could be two groups, one inoculated with the usual vaccine acting as controls and the other getting 
the new vaccine. 
The inoculation against smallpox started the debate about human experimentation.  More than 
two hundred years later humanity faces the same old problem.  But this time the possible aggressor 
is not nature itself, but humans. 
 
 
16  (1991) 756 F Supp 12; (1991) F2d 1370. 
